![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1312859 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of NAGK mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1305057 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of NAGK mRNA | CTD | PMID:25380136 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1305057 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NAGK mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAGK mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1312859 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA | CTD | PMID:20106945, PMID:21632981 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1305057 | 6480464 | 2, 6-dinitrotoluene affects the expression of NAGK mRNA | CTD | PMID:21346803 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1305057 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of NAGK mRNA | CTD | PMID:25380136 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NAGK mRNA | CTD | PMID:30807115 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzoapyrene promotes the reaction [AHR protein binds to NAGK promoter] | CTD | PMID:19654925 | benzo[a]pyrene | decreases methylation | ISO | RGD:1312859 | 6480464 | Benzoapyrene results in decreased methylation of NAGK promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1312859 | 6480464 | Benzoapyrene results in increased expression of NAGK mRNA | CTD | PMID:21632981 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of NAGK mRNA | CTD | PMID:20713471, PMID:22228805 | bisphenol A | increases expression | ISO | RGD:1305057 | 6480464 | bisphenol A results in increased expression of NAGK mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1305057 | 6480464 | bisphenol A results in decreased expression of NAGK mRNA | CTD | PMID:30816183 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes, Carbon results in decreased expression of NAGK mRNA | CTD | PMID:25620056 | cisplatin | increases expression | ISO | RGD:1312859 | 6480464 | Cisplatin results in increased expression of NAGK mRNA | CTD | PMID:27594783 | clofibric acid | affects expression | ISO | RGD:1305057 | 6480464 | Clofibric Acid affects the expression of NAGK mRNA | CTD | PMID:17602206 | cobalt dichloride | decreases expression | ISO | RGD:1312859 | 6480464 | cobaltous chloride results in decreased expression of NAGK mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | ISO | RGD:1312859 | 6480464 | Copper Sulfate results in decreased expression of NAGK mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | RGD:1312859 | 6480464 | Cyclosporine results in increased expression of NAGK mRNA | CTD | PMID:20106945 | cyproconazole | increases expression | EXP | | 6480464 | cyproconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | dibutyl phthalate | decreases expression | ISO | RGD:1305057 | 6480464 | Dibutyl Phthalate results in decreased expression of NAGK mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of NAGK mRNA | CTD | PMID:17361019 | dorsomorphin | multiple interactions | ISO | RGD:1312859 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | elemental selenium | increases expression | ISO | RGD:1312859 | 6480464 | Selenium results in increased expression of NAGK mRNA | CTD | PMID:19244175 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | ethyl methanesulfonate | increases expression | ISO | RGD:1312859 | 6480464 | Ethyl Methanesulfonate results in increased expression of NAGK mRNA | CTD | PMID:23649840 | finasteride | increases expression | ISO | RGD:1305057 | 6480464 | Finasteride results in increased expression of NAGK mRNA | CTD | PMID:24136188 | flutamide | decreases expression | ISO | RGD:1305057 | 6480464 | Flutamide results in decreased expression of NAGK mRNA | CTD | PMID:24793618 | formaldehyde | increases expression | ISO | RGD:1312859 | 6480464 | Formaldehyde results in increased expression of NAGK mRNA | CTD | PMID:23649840 | leflunomide | decreases expression | ISO | RGD:1312859 | 6480464 | leflunomide results in decreased expression of NAGK mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | RGD:1312859 | 6480464 | Methyl Methanesulfonate results in increased expression of NAGK mRNA | CTD | PMID:23649840 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NAGK mRNA | CTD | PMID:22776087 | N-nitrosodimethylamine | increases expression | ISO | RGD:1305057 | 6480464 | Dimethylnitrosamine results in increased expression of NAGK mRNA | CTD | PMID:25380136 | nickel atom | decreases expression | ISO | RGD:1312859 | 6480464 | Nickel results in decreased expression of NAGK mRNA | CTD | PMID:23195993 | ochratoxin A | decreases expression | ISO | RGD:1312859 | 6480464 | ochratoxin A results in decreased expression of NAGK mRNA | CTD | PMID:22124623 | ochratoxin A | decreases expression | ISO | RGD:1305057 | 6480464 | ochratoxin A results in decreased expression of NAGK mRNA | CTD | PMID:22124623 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of NAGK mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1312859 | 6480464 | Acetaminophen results in increased expression of NAGK mRNA | CTD | PMID:22230336 | pentachlorophenol | increases expression | EXP | | 6480464 | Pentachlorophenol results in increased expression of NAGK mRNA | CTD | PMID:23892564 | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluorononanoic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of NAGK mRNA] | CTD | PMID:28558994 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NAGK mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of NAGK mRNA | CTD | PMID:19482888 | phenylmercury acetate | increases expression | ISO | RGD:1312859 | 6480464 | Phenylmercuric Acetate results in increased expression of NAGK mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1312859 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NAGK mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:1312859 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAGK mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of NAGK mRNA | CTD | PMID:18301758, PMID:23811191 | potassium chromate | decreases expression | ISO | RGD:1312859 | 6480464 | potassium chromateVI results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1312859 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | SB 431542 | multiple interactions | ISO | RGD:1312859 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | selenium atom | increases expression | ISO | RGD:1312859 | 6480464 | Selenium results in increased expression of NAGK mRNA | CTD | PMID:19244175 | Soman | increases expression | ISO | RGD:1305057 | 6480464 | Soman results in increased expression of NAGK mRNA | CTD | PMID:19281266 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of NAGK mRNA | CTD | PMID:31919559 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NAGK mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | RGD:1312859 | 6480464 | Valproic Acid affects the expression of NAGK mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1312859 | 6480464 | Valproic Acid results in increased expression of NAGK mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1312859 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NAGK mRNA | CTD | PMID:27188386 | vitamin E | increases expression | ISO | RGD:1312859 | 6480464 | Vitamin E results in increased expression of NAGK mRNA | CTD | PMID:19244175 | |